Paysign (NASDAQ:PAYS – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 0.370-0.380 for the period, compared to the consensus estimate of 0.510. The company issued revenue guidance of $114.0 million-$117.0 million, compared to the consensus revenue estimate of $114.7 million.
Analysts Set New Price Targets
PAYS has been the topic of several research reports. Ladenburg Thalmann & Co. Inc. boosted their price target on shares of Paysign from $14.00 to $15.25 and gave the stock a “buy” rating in a research report on Wednesday. Maxim Group cut shares of Paysign from a “buy” rating to a “hold” rating in a research note on Wednesday. Weiss Ratings upgraded shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. DA Davidson cut their price target on shares of Paysign from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Lake Street Capital increased their price objective on shares of Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a research report on Tuesday, September 15th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Paysign presently has an average rating of “Moderate Buy” and an average target price of $14.81.
Read Our Latest Report on PAYS
Paysign Trading Down 6.5%
NASDAQ:PAYS opened at $9.48 on Thursday. Paysign has a twelve month low of $3.08 and a twelve month high of $16.15. The company has a market cap of $535.24 million, a price-to-earnings ratio of 28.73 and a beta of 0.92. The stock has a fifty day simple moving average of $13.76 and a 200-day simple moving average of $8.66.
Paysign (NASDAQ:PAYS – Get Free Report) last released its quarterly earnings data on Monday, November 9th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.02. The company had revenue of $30.80 million during the quarter, compared to analysts’ expectations of $29.02 million. Paysign had a net margin of 18.48% and a return on equity of 37.20%. As a group, equities research analysts predict that Paysign will post 0.38 EPS for the current fiscal year.
Insiders Place Their Bets
In other Paysign news, EVP Joan Herman sold 38,900 shares of the firm’s stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $11.74, for a total transaction of $456,686.00. Following the transaction, the executive vice president directly owned 609,421 shares in the company, valued at $7,154,602.54. This trade represents a 6.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael Ngo sold 79,925 shares of the company’s stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $12.74, for a total value of $1,018,244.50. Following the completion of the sale, the insider owned 2,350,000 shares of the company’s stock, valued at $29,939,000. This represents a 3.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 259,904 shares of company stock worth $3,402,424 in the last ninety days. 24.50% of the stock is owned by company insiders.
Top Paysign Stories
Here are a few of the latest stories about PAYS:
- Positive Sentiment: Q3 results beat consensus: Paysign reported EPS of $0.11 versus $0.09 expected and revenue of $30.8 million versus $29.02 million expected. Paysign sees strong trading volume following strong earnings
- Negative Sentiment: Concern that a major customer is pulling back is pressuring expectations for future revenue. Paysign’s FY2026 EPS guidance of $0.37–$0.38 is also below the $0.51 consensus, although its revenue range of $114–$117 million is slightly above the $114.7 million consensus. Paysign falls as customer’s pullback weighs on future revenue
- Negative Sentiment: Maxim Group downgraded Paysign from Buy to Hold, while DA Davidson cut its price target from $15 to $14, though it maintained a Buy rating.
Paysign Company Profile
Paysign, Inc. provides prepaid card programs, payment processing and related financial technology services. Its platform supports organizations that need to distribute funds and manage payments, including businesses in the healthcare sector. The company serves plasma collection centers with donor compensation and payment solutions, and works with pharmaceutical companies on patient assistance and affordability programs. Its services also support payments for clinical trials and other disbursement needs.
Read More
- Five stocks we like better than Paysign
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.
